JP4728484B2 - 多環２−アミノチアゾール系、その製造方法およびそれを含む医薬 - Google Patents

多環２−アミノチアゾール系、その製造方法およびそれを含む医薬 Download PDF

Info

Publication number
JP4728484B2
JP4728484B2 JP2000602222A JP2000602222A JP4728484B2 JP 4728484 B2 JP4728484 B2 JP 4728484B2 JP 2000602222 A JP2000602222 A JP 2000602222A JP 2000602222 A JP2000602222 A JP 2000602222A JP 4728484 B2 JP4728484 B2 JP 4728484B2
Authority
JP
Japan
Prior art keywords
alkyl
phenyl
acid
conh
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2000602222A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002538148A5 (https=
JP2002538148A (ja
Inventor
ゲーアハルト・イェーネ
カール・ガイゼン
ハンス−ヨッヘン・ラング
マルティン・ビッケル
Original Assignee
サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング filed Critical サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング
Publication of JP2002538148A publication Critical patent/JP2002538148A/ja
Publication of JP2002538148A5 publication Critical patent/JP2002538148A5/ja
Application granted granted Critical
Publication of JP4728484B2 publication Critical patent/JP4728484B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2000602222A 1999-02-26 2000-02-05 多環２−アミノチアゾール系、その製造方法およびそれを含む医薬 Expired - Fee Related JP4728484B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19908538.2 1999-02-26
DE19908538A DE19908538A1 (de) 1999-02-26 1999-02-26 Polycyclische 2-Amino-Thiazol Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen
PCT/EP2000/000924 WO2000051995A1 (de) 1999-02-26 2000-02-05 Polycyclische 2-amino-thiazol systeme, verfahren zu ihrer herstellung und arzneimittel enthaltend diese verbindungen

Publications (3)

Publication Number Publication Date
JP2002538148A JP2002538148A (ja) 2002-11-12
JP2002538148A5 JP2002538148A5 (https=) 2007-04-05
JP4728484B2 true JP4728484B2 (ja) 2011-07-20

Family

ID=7899082

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000602222A Expired - Fee Related JP4728484B2 (ja) 1999-02-26 2000-02-05 多環２−アミノチアゾール系、その製造方法およびそれを含む医薬

Country Status (15)

Country Link
US (1) US6251922B1 (https=)
EP (1) EP1157015B1 (https=)
JP (1) JP4728484B2 (https=)
KR (1) KR20010102390A (https=)
CN (1) CN1148362C (https=)
AT (1) ATE295357T1 (https=)
AU (1) AU763111B2 (https=)
BR (1) BR0008510A (https=)
CA (1) CA2364900A1 (https=)
DE (2) DE19908538A1 (https=)
ES (1) ES2240070T3 (https=)
HK (1) HK1043117B (https=)
PT (1) PT1157015E (https=)
WO (1) WO2000051995A1 (https=)
ZA (1) ZA200106198B (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19908537A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Verwendung von polycyclischen 2-Amino-Thiazol Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
US7732484B2 (en) * 2000-08-01 2010-06-08 University Of Virginia Patent Foundation Use of selective adenosine A1 receptor allosteric enhancers to manipulate angiogenesis
JP2005529846A (ja) * 2002-01-16 2005-10-06 ユニバーシティ オブ バージニア パテント ファウンデーション Ａ１アデノシン受容体の２−アミノチアゾールアロステリックエンハンサ
ES2480994T3 (es) 2008-03-31 2014-07-29 Genentech, Inc. Compuestos de tipo benzopirano y benzoxepina inhibidores de PI3K y métodos de uso
ES2558742T3 (es) 2009-09-28 2016-02-08 F. Hoffmann-La Roche Ag Compuestos inhibidores de PI3K de benzoxepina y métodos de uso
ES2570569T3 (es) 2009-09-28 2016-05-19 Hoffmann La Roche Compuestos de benzoxazepina como inhibidores de la PI3K y métodos de uso
JP5728487B2 (ja) * 2009-10-29 2015-06-03 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ 三環式ヘテロ環化合物
WO2012126901A1 (en) 2011-03-21 2012-09-27 F. Hoffmann-La Roche Ag Benzoxazepin compounds selective for pi3k p110 delta and methods of use
ES2859478T3 (es) 2016-09-02 2021-10-04 Bristol Myers Squibb Co Compuestos heterocíclicos tricíclicos sustituidos
WO2019032631A1 (en) 2017-08-09 2019-02-14 Bristol-Myers Squibb Company Oxime ether compounds
US11046646B2 (en) 2017-08-09 2021-06-29 Bristol-Myers Squibb Company Alkylphenyl compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4082773A (en) * 1972-07-03 1978-04-04 E. R. Squibb & Sons, Inc. Tricyclic tetrahydro naphthaleneols and related compounds
DE2640358A1 (de) * 1976-09-08 1978-03-16 Hoechst Ag Thiazolidinderivate und verfahren zu ihrer herstellung
CA1292226C (en) * 1986-01-16 1991-11-19 Terumi Hachiya Indenothiazole derivative and process for preparing the same
IE68593B1 (en) 1989-12-06 1996-06-26 Sanofi Sa Heterocyclic substituted acylaminothiazoles their preparation and pharmaceutical compositions containing them
TW416953B (en) * 1996-09-25 2001-01-01 Takeda Chemical Industries Ltd Tricyclic compounds for eliciting a prostaglandin I2 receptor agonistic effect, their production and use
AU3289299A (en) * 1998-02-19 1999-09-06 Tularik Inc. Antiviral agents
DE19831878C2 (de) * 1998-07-17 2001-05-17 Aventis Pharma Gmbh Polycyclische Thiazolidin-2-yliden Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19908537A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Verwendung von polycyclischen 2-Amino-Thiazol Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas

Also Published As

Publication number Publication date
HK1043117B (zh) 2004-10-08
DE50010285D1 (de) 2005-06-16
AU763111B2 (en) 2003-07-10
CN1148362C (zh) 2004-05-05
ZA200106198B (en) 2002-05-03
BR0008510A (pt) 2002-02-05
DE19908538A1 (de) 2000-08-31
ES2240070T3 (es) 2005-10-16
JP2002538148A (ja) 2002-11-12
US6251922B1 (en) 2001-06-26
EP1157015A1 (de) 2001-11-28
ATE295357T1 (de) 2005-05-15
PT1157015E (pt) 2005-08-31
EP1157015B1 (de) 2005-05-11
KR20010102390A (ko) 2001-11-15
HK1043117A1 (en) 2002-09-06
CA2364900A1 (en) 2000-09-08
WO2000051995A1 (de) 2000-09-08
AU3278200A (en) 2000-09-21
CN1344263A (zh) 2002-04-10

Similar Documents

Publication Publication Date Title
JP4728483B2 (ja) 肥満の予防または治療のための医薬の製造のための多環２−アミノチアゾール系の使用
JP4728484B2 (ja) 多環２−アミノチアゾール系、その製造方法およびそれを含む医薬
RU2236405C2 (ru) Полициклические тиазолидин-2-илиденовые амины, содержащие их лекарственные средства и способ получения лекарственного средства
JP4728482B2 (ja) 肥満症を予防または治療するための薬剤の製造における多環式チアゾール系の使用
JP4728485B2 (ja) 多環式チアゾール系および食欲抑制剤としてのその使用
JP4658332B2 (ja) 多環２−アミノジヒドロチアゾール系、その製造方法および医薬としての使用
MXPA01007281A (en) Polycyclic 2-amino-thiazole systems, method for the production thereof and medicament containing said compounds
MXPA01007494A (en) Polycyclic thiazole systems and their utilization as anorectics
MXPA01007452A (en) Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylaxis or treatment of obesity
MXPA01007542A (es) Uso de sistemas de tiazol policiclico para producir medicamentos para prevenir o tratar obesidad

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070126

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070126

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20090929

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100817

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101008

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20101008

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101207

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110107

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110329

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110415

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140422

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees